Open Label Trial to Assess Iressa in Prostate Cancer Patients

Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer

NCT00242918 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of ASP3550 in Patients With Prostate Cancer

NCT00568516 ·Status: COMPLETED ·Phase: PHASE2

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

NCT00668083 ·Status: COMPLETED

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

NCT01964170 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

NCT01302041 ·Status: COMPLETED ·Phase: PHASE2

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Find Maintenance Dose for Periodic Administration of ASP3550

NCT01261572 ·Status: COMPLETED ·Phase: PHASE2

Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State

NCT01560858 ·Status: COMPLETED

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

NCT02960022 ·Status: RECRUITING ·Phase: PHASE2

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED

A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

NCT03087903 ·Status: COMPLETED ·Phase: NA

An Open Label Prostate Cancer Study in Japanese Patients

NCT01351688 ·Status: COMPLETED ·Phase: PHASE1

Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy

NCT00278993 ·Status: COMPLETED ·Phase: PHASE2

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

NCT00596895 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

NCT00564928 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2

Response of Patients on Surveillance for Prostate Cancer to Dutasteride

NCT01525914 ·Status: COMPLETED

Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

NCT00058539 ·Status: COMPLETED ·Phase: PHASE2

Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer

NCT06236789 ·Status: RECRUITING

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

NCT00038662 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma

NCT06015321 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

NCT03619980 ·Status: COMPLETED

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

NCT01296243 ·Status: UNKNOWN ·Phase: PHASE2

Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration

NCT02963155 ·Status: UNKNOWN ·Phase: NA

Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154

NCT00535834 ·Status: COMPLETED